The 340B Drug Pricing Program has been a vital resource for healthcare providers serving underserved communities, enabling them to purchase medications at discounted prices. As healthcare changes, it’s important for providers to understand future trends in the 340B program. This will help them stay competitive, follow the rules, and manage their medical services effectively. In this article, we’ll explore the key trends shaping the 340B program and how expert consultants can help healthcare providers navigate these changes.
1. Increased Scrutiny and Regulation
The 340B program has faced increased scrutiny from both federal agencies and industry stakeholders in recent years. This includes calls for stricter compliance standards, auditing procedures, and transparency in the way savings from the 340B program are used. The Department of Health and Human Services (HHS) and the Health Resources and Services Administration (HRSA) are both taking a more active role in monitoring compliance, with penalties for violations becoming more severe.
